nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—restless legs syndrome—Pregabalin—epilepsy syndrome	0.129	0.267	CpDpCtD
Pramipexole—ADRA2A—epilepsy syndrome	0.122	0.63	CbGaD
Pramipexole—restless legs syndrome—Carbamazepine—epilepsy syndrome	0.115	0.238	CpDpCtD
Pramipexole—restless legs syndrome—Clonazepam—epilepsy syndrome	0.0921	0.19	CpDpCtD
Pramipexole—restless legs syndrome—Gabapentin—epilepsy syndrome	0.0742	0.153	CpDpCtD
Pramipexole—HTR2A—epilepsy syndrome	0.0717	0.37	CbGaD
Pramipexole—Parkinson's disease—Clonazepam—epilepsy syndrome	0.0404	0.0835	CpDpCtD
Pramipexole—Parkinson's disease—Gabapentin—epilepsy syndrome	0.0326	0.0673	CpDpCtD
Pramipexole—HTR1D—meninx—epilepsy syndrome	0.00518	0.102	CbGeAlD
Pramipexole—HTR2A—phrenic nerve—epilepsy syndrome	0.00278	0.0546	CbGeAlD
Pramipexole—DRD3—telencephalic ventricle—epilepsy syndrome	0.00211	0.0415	CbGeAlD
Pramipexole—DRD1—telencephalic ventricle—epilepsy syndrome	0.00151	0.0297	CbGeAlD
Pramipexole—HTR2A—locus ceruleus—epilepsy syndrome	0.00124	0.0244	CbGeAlD
Pramipexole—DRD5—ganglion—epilepsy syndrome	0.00123	0.0242	CbGeAlD
Pramipexole—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00123	0.024	CbGeAlD
Pramipexole—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00119	0.0233	CbGeAlD
Pramipexole—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00118	0.0231	CbGeAlD
Pramipexole—HTR2A—cerebellar cortex—epilepsy syndrome	0.00101	0.0199	CbGeAlD
Pramipexole—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00099	0.0194	CbGeAlD
Pramipexole—HTR2A—vagus nerve—epilepsy syndrome	0.000952	0.0187	CbGeAlD
Pramipexole—DRD1—ganglion—epilepsy syndrome	0.000942	0.0185	CbGeAlD
Pramipexole—DRD2—telencephalic ventricle—epilepsy syndrome	0.000894	0.0175	CbGeAlD
Pramipexole—HTR1B—ganglion—epilepsy syndrome	0.000763	0.015	CbGeAlD
Pramipexole—SLC22A1—ganglion—epilepsy syndrome	0.000746	0.0146	CbGeAlD
Pramipexole—HTR1D—ganglion—epilepsy syndrome	0.000739	0.0145	CbGeAlD
Pramipexole—HTR2C—ganglion—epilepsy syndrome	0.000732	0.0144	CbGeAlD
Pramipexole—HTR2A—pons—epilepsy syndrome	0.000717	0.0141	CbGeAlD
Pramipexole—HTR2A—autonomic nervous system—epilepsy syndrome	0.000661	0.013	CbGeAlD
Pramipexole—HTR1A—ganglion—epilepsy syndrome	0.000616	0.0121	CbGeAlD
Pramipexole—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00059	0.0116	CbGeAlD
Pramipexole—DRD2—ganglion—epilepsy syndrome	0.000557	0.0109	CbGeAlD
Pramipexole—DRD5—forebrain—epilepsy syndrome	0.000517	0.0101	CbGeAlD
Pramipexole—DRD5—telencephalon—epilepsy syndrome	0.000476	0.00933	CbGeAlD
Pramipexole—HTR1A—hindbrain—epilepsy syndrome	0.000467	0.00916	CbGeAlD
Pramipexole—DRD2—hindbrain—epilepsy syndrome	0.000422	0.00828	CbGeAlD
Pramipexole—DRD1—brainstem—epilepsy syndrome	0.00041	0.00803	CbGeAlD
Pramipexole—DRD1—forebrain—epilepsy syndrome	0.000395	0.00775	CbGeAlD
Pramipexole—HTR2A—ganglion—epilepsy syndrome	0.000367	0.0072	CbGeAlD
Pramipexole—DRD1—telencephalon—epilepsy syndrome	0.000363	0.00713	CbGeAlD
Pramipexole—HTR1B—brainstem—epilepsy syndrome	0.000332	0.00651	CbGeAlD
Pramipexole—DRD4—brain—epilepsy syndrome	0.000326	0.00639	CbGeAlD
Pramipexole—HTR1D—brainstem—epilepsy syndrome	0.000321	0.0063	CbGeAlD
Pramipexole—HTR1B—forebrain—epilepsy syndrome	0.00032	0.00628	CbGeAlD
Pramipexole—HTR2C—brainstem—epilepsy syndrome	0.000318	0.00624	CbGeAlD
Pramipexole—DRD3—head—epilepsy syndrome	0.000316	0.0062	CbGeAlD
Pramipexole—SLC22A1—forebrain—epilepsy syndrome	0.000313	0.00614	CbGeAlD
Pramipexole—HTR1D—forebrain—epilepsy syndrome	0.00031	0.00608	CbGeAlD
Pramipexole—HTR2C—forebrain—epilepsy syndrome	0.000307	0.00602	CbGeAlD
Pramipexole—DRD3—nervous system—epilepsy syndrome	0.0003	0.00588	CbGeAlD
Pramipexole—DRD5—head—epilepsy syndrome	0.000296	0.00581	CbGeAlD
Pramipexole—HTR1B—telencephalon—epilepsy syndrome	0.000294	0.00578	CbGeAlD
Pramipexole—DRD3—central nervous system—epilepsy syndrome	0.000288	0.00566	CbGeAlD
Pramipexole—HTR2B—forebrain—epilepsy syndrome	0.000288	0.00566	CbGeAlD
Pramipexole—SLC22A1—telencephalon—epilepsy syndrome	0.000288	0.00564	CbGeAlD
Pramipexole—HTR1D—telencephalon—epilepsy syndrome	0.000285	0.00559	CbGeAlD
Pramipexole—HTR2C—telencephalon—epilepsy syndrome	0.000282	0.00554	CbGeAlD
Pramipexole—DRD5—nervous system—epilepsy syndrome	0.000281	0.00551	CbGeAlD
Pramipexole—HTR2A—hindbrain—epilepsy syndrome	0.000278	0.00546	CbGeAlD
Pramipexole—DRD5—central nervous system—epilepsy syndrome	0.00027	0.0053	CbGeAlD
Pramipexole—HTR1A—brainstem—epilepsy syndrome	0.000268	0.00525	CbGeAlD
Pramipexole—HTR2B—telencephalon—epilepsy syndrome	0.000265	0.0052	CbGeAlD
Pramipexole—DRD1—midbrain—epilepsy syndrome	0.000261	0.00512	CbGeAlD
Pramipexole—HTR1A—forebrain—epilepsy syndrome	0.000258	0.00507	CbGeAlD
Pramipexole—DRD2—brainstem—epilepsy syndrome	0.000242	0.00474	CbGeAlD
Pramipexole—HTR1A—telencephalon—epilepsy syndrome	0.000238	0.00466	CbGeAlD
Pramipexole—DRD2—forebrain—epilepsy syndrome	0.000234	0.00458	CbGeAlD
Pramipexole—DRD3—brain—epilepsy syndrome	0.000229	0.00449	CbGeAlD
Pramipexole—DRD1—head—epilepsy syndrome	0.000226	0.00444	CbGeAlD
Pramipexole—HTR2C—medulla oblongata—epilepsy syndrome	0.000222	0.00435	CbGeAlD
Pramipexole—DRD2—telencephalon—epilepsy syndrome	0.000215	0.00421	CbGeAlD
Pramipexole—DRD5—brain—epilepsy syndrome	0.000215	0.00421	CbGeAlD
Pramipexole—DRD1—nervous system—epilepsy syndrome	0.000215	0.00421	CbGeAlD
Pramipexole—HTR1B—midbrain—epilepsy syndrome	0.000211	0.00415	CbGeAlD
Pramipexole—ADRA2C—telencephalon—epilepsy syndrome	0.000209	0.00409	CbGeAlD
Pramipexole—DRD1—central nervous system—epilepsy syndrome	0.000207	0.00405	CbGeAlD
Pramipexole—HTR1B—spinal cord—epilepsy syndrome	0.000206	0.00405	CbGeAlD
Pramipexole—HTR1D—midbrain—epilepsy syndrome	0.000205	0.00402	CbGeAlD
Pramipexole—HTR2C—midbrain—epilepsy syndrome	0.000203	0.00398	CbGeAlD
Pramipexole—HTR2C—spinal cord—epilepsy syndrome	0.000198	0.00388	CbGeAlD
Pramipexole—HTR1B—head—epilepsy syndrome	0.000183	0.0036	CbGeAlD
Pramipexole—ADRA2A—forebrain—epilepsy syndrome	0.000181	0.00355	CbGeAlD
Pramipexole—SLC22A1—head—epilepsy syndrome	0.000179	0.00351	CbGeAlD
Pramipexole—HTR1D—head—epilepsy syndrome	0.000178	0.00348	CbGeAlD
Pramipexole—HTR2C—head—epilepsy syndrome	0.000176	0.00345	CbGeAlD
Pramipexole—HTR1B—nervous system—epilepsy syndrome	0.000174	0.00341	CbGeAlD
Pramipexole—HTR1A—midbrain—epilepsy syndrome	0.000171	0.00335	CbGeAlD
Pramipexole—SLC22A1—nervous system—epilepsy syndrome	0.00017	0.00333	CbGeAlD
Pramipexole—HTR1D—nervous system—epilepsy syndrome	0.000168	0.0033	CbGeAlD
Pramipexole—HTR1B—central nervous system—epilepsy syndrome	0.000167	0.00328	CbGeAlD
Pramipexole—HTR2C—nervous system—epilepsy syndrome	0.000167	0.00327	CbGeAlD
Pramipexole—ADRA2A—telencephalon—epilepsy syndrome	0.000167	0.00327	CbGeAlD
Pramipexole—HTR1A—spinal cord—epilepsy syndrome	0.000167	0.00327	CbGeAlD
Pramipexole—HTR2B—head—epilepsy syndrome	0.000165	0.00324	CbGeAlD
Pramipexole—ADRA2C—medulla oblongata—epilepsy syndrome	0.000164	0.00322	CbGeAlD
Pramipexole—DRD1—brain—epilepsy syndrome	0.000164	0.00322	CbGeAlD
Pramipexole—SLC22A1—central nervous system—epilepsy syndrome	0.000164	0.00321	CbGeAlD
Pramipexole—HTR1D—central nervous system—epilepsy syndrome	0.000162	0.00318	CbGeAlD
Pramipexole—HTR2C—central nervous system—epilepsy syndrome	0.00016	0.00315	CbGeAlD
Pramipexole—HTR2A—brainstem—epilepsy syndrome	0.00016	0.00313	CbGeAlD
Pramipexole—HTR2B—nervous system—epilepsy syndrome	0.000157	0.00307	CbGeAlD
Pramipexole—DRD2—midbrain—epilepsy syndrome	0.000154	0.00302	CbGeAlD
Pramipexole—HTR2A—forebrain—epilepsy syndrome	0.000154	0.00302	CbGeAlD
Pramipexole—HTR2B—central nervous system—epilepsy syndrome	0.000151	0.00296	CbGeAlD
Pramipexole—ADRA2C—midbrain—epilepsy syndrome	0.00015	0.00294	CbGeAlD
Pramipexole—HTR1A—head—epilepsy syndrome	0.000148	0.0029	CbGeAlD
Pramipexole—ADRA2C—spinal cord—epilepsy syndrome	0.000146	0.00287	CbGeAlD
Pramipexole—HTR2A—telencephalon—epilepsy syndrome	0.000142	0.00278	CbGeAlD
Pramipexole—HTR1A—nervous system—epilepsy syndrome	0.00014	0.00275	CbGeAlD
Pramipexole—HTR1A—central nervous system—epilepsy syndrome	0.000135	0.00265	CbGeAlD
Pramipexole—DRD2—head—epilepsy syndrome	0.000134	0.00262	CbGeAlD
Pramipexole—HTR1B—brain—epilepsy syndrome	0.000133	0.00261	CbGeAlD
Pramipexole—HTR1A—cerebellum—epilepsy syndrome	0.000132	0.00259	CbGeAlD
Pramipexole—ADRA2A—medulla oblongata—epilepsy syndrome	0.000131	0.00257	CbGeAlD
Pramipexole—ADRA2C—head—epilepsy syndrome	0.00013	0.00255	CbGeAlD
Pramipexole—SLC22A1—brain—epilepsy syndrome	0.00013	0.00255	CbGeAlD
Pramipexole—HTR1D—brain—epilepsy syndrome	0.000129	0.00252	CbGeAlD
Pramipexole—HTR2C—brain—epilepsy syndrome	0.000127	0.0025	CbGeAlD
Pramipexole—DRD2—nervous system—epilepsy syndrome	0.000127	0.00249	CbGeAlD
Pramipexole—ADRA2C—nervous system—epilepsy syndrome	0.000123	0.00242	CbGeAlD
Pramipexole—DRD2—central nervous system—epilepsy syndrome	0.000122	0.00239	CbGeAlD
Pramipexole—HTR2B—brain—epilepsy syndrome	0.00012	0.00235	CbGeAlD
Pramipexole—ADRA2A—midbrain—epilepsy syndrome	0.00012	0.00235	CbGeAlD
Pramipexole—DRD2—cerebellum—epilepsy syndrome	0.000119	0.00234	CbGeAlD
Pramipexole—ADRA2C—central nervous system—epilepsy syndrome	0.000119	0.00233	CbGeAlD
Pramipexole—ADRA2A—spinal cord—epilepsy syndrome	0.000117	0.00229	CbGeAlD
Pramipexole—ADRA2C—cerebellum—epilepsy syndrome	0.000116	0.00227	CbGeAlD
Pramipexole—HTR2A—medulla oblongata—epilepsy syndrome	0.000111	0.00218	CbGeAlD
Pramipexole—HTR1A—brain—epilepsy syndrome	0.000107	0.0021	CbGeAlD
Pramipexole—ADRA2A—head—epilepsy syndrome	0.000104	0.00203	CbGeAlD
Pramipexole—HTR2A—midbrain—epilepsy syndrome	0.000102	0.00199	CbGeAlD
Pramipexole—HTR2A—spinal cord—epilepsy syndrome	9.92e-05	0.00195	CbGeAlD
Pramipexole—ADRA2A—nervous system—epilepsy syndrome	9.83e-05	0.00193	CbGeAlD
Pramipexole—DRD2—brain—epilepsy syndrome	9.69e-05	0.0019	CbGeAlD
Pramipexole—ADRA2A—central nervous system—epilepsy syndrome	9.47e-05	0.00186	CbGeAlD
Pramipexole—ADRA2C—brain—epilepsy syndrome	9.42e-05	0.00185	CbGeAlD
Pramipexole—ADRA2A—cerebellum—epilepsy syndrome	9.25e-05	0.00181	CbGeAlD
Pramipexole—HTR2A—head—epilepsy syndrome	8.82e-05	0.00173	CbGeAlD
Pramipexole—HTR2A—nervous system—epilepsy syndrome	8.36e-05	0.00164	CbGeAlD
Pramipexole—HTR2A—central nervous system—epilepsy syndrome	8.05e-05	0.00158	CbGeAlD
Pramipexole—HTR2A—cerebellum—epilepsy syndrome	7.87e-05	0.00154	CbGeAlD
Pramipexole—ADRA2A—brain—epilepsy syndrome	7.52e-05	0.00147	CbGeAlD
Pramipexole—HTR2A—brain—epilepsy syndrome	6.39e-05	0.00125	CbGeAlD
Pramipexole—Diarrhoea—Clonazepam—epilepsy syndrome	1.23e-05	6.83e-05	CcSEcCtD
Pramipexole—Anaemia—Gabapentin—epilepsy syndrome	1.23e-05	6.83e-05	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.23e-05	6.81e-05	CcSEcCtD
Pramipexole—Hypotension—Valproic Acid—epilepsy syndrome	1.22e-05	6.79e-05	CcSEcCtD
Pramipexole—Asthenia—Carbamazepine—epilepsy syndrome	1.22e-05	6.79e-05	CcSEcCtD
Pramipexole—Agitation—Gabapentin—epilepsy syndrome	1.22e-05	6.79e-05	CcSEcCtD
Pramipexole—Diarrhoea—Phenytoin—epilepsy syndrome	1.22e-05	6.79e-05	CcSEcCtD
Pramipexole—Discomfort—Pregabalin—epilepsy syndrome	1.22e-05	6.78e-05	CcSEcCtD
Pramipexole—Nausea—Fosphenytoin—epilepsy syndrome	1.22e-05	6.77e-05	CcSEcCtD
Pramipexole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.22e-05	6.75e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.21e-05	6.74e-05	CcSEcCtD
Pramipexole—Vomiting—Felbamate—epilepsy syndrome	1.21e-05	6.73e-05	CcSEcCtD
Pramipexole—Dry mouth—Pregabalin—epilepsy syndrome	1.21e-05	6.71e-05	CcSEcCtD
Pramipexole—Pruritus—Carbamazepine—epilepsy syndrome	1.21e-05	6.7e-05	CcSEcCtD
Pramipexole—Rash—Felbamate—epilepsy syndrome	1.2e-05	6.67e-05	CcSEcCtD
Pramipexole—Eye disorder—Topiramate—epilepsy syndrome	1.2e-05	6.67e-05	CcSEcCtD
Pramipexole—Dermatitis—Felbamate—epilepsy syndrome	1.2e-05	6.67e-05	CcSEcCtD
Pramipexole—Malaise—Gabapentin—epilepsy syndrome	1.2e-05	6.66e-05	CcSEcCtD
Pramipexole—Tinnitus—Topiramate—epilepsy syndrome	1.2e-05	6.66e-05	CcSEcCtD
Pramipexole—Vertigo—Gabapentin—epilepsy syndrome	1.2e-05	6.64e-05	CcSEcCtD
Pramipexole—Headache—Felbamate—epilepsy syndrome	1.19e-05	6.63e-05	CcSEcCtD
Pramipexole—Confusional state—Pregabalin—epilepsy syndrome	1.19e-05	6.63e-05	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.19e-05	6.63e-05	CcSEcCtD
Pramipexole—Flushing—Topiramate—epilepsy syndrome	1.19e-05	6.63e-05	CcSEcCtD
Pramipexole—Cardiac disorder—Topiramate—epilepsy syndrome	1.19e-05	6.63e-05	CcSEcCtD
Pramipexole—Syncope—Gabapentin—epilepsy syndrome	1.19e-05	6.62e-05	CcSEcCtD
Pramipexole—Leukopenia—Gabapentin—epilepsy syndrome	1.19e-05	6.61e-05	CcSEcCtD
Pramipexole—Dizziness—Clonazepam—epilepsy syndrome	1.19e-05	6.6e-05	CcSEcCtD
Pramipexole—Nausea—Vigabatrin—epilepsy syndrome	1.19e-05	6.6e-05	CcSEcCtD
Pramipexole—Vomiting—Zonisamide—epilepsy syndrome	1.19e-05	6.59e-05	CcSEcCtD
Pramipexole—Insomnia—Valproic Acid—epilepsy syndrome	1.18e-05	6.58e-05	CcSEcCtD
Pramipexole—Oedema—Pregabalin—epilepsy syndrome	1.18e-05	6.57e-05	CcSEcCtD
Pramipexole—Asthenia—Lamotrigine—epilepsy syndrome	1.18e-05	6.57e-05	CcSEcCtD
Pramipexole—Dizziness—Phenytoin—epilepsy syndrome	1.18e-05	6.56e-05	CcSEcCtD
Pramipexole—Rash—Zonisamide—epilepsy syndrome	1.18e-05	6.53e-05	CcSEcCtD
Pramipexole—Infection—Pregabalin—epilepsy syndrome	1.18e-05	6.53e-05	CcSEcCtD
Pramipexole—Paraesthesia—Valproic Acid—epilepsy syndrome	1.18e-05	6.53e-05	CcSEcCtD
Pramipexole—Palpitations—Gabapentin—epilepsy syndrome	1.18e-05	6.53e-05	CcSEcCtD
Pramipexole—Dermatitis—Zonisamide—epilepsy syndrome	1.18e-05	6.53e-05	CcSEcCtD
Pramipexole—Dizziness—Oxcarbazepine—epilepsy syndrome	1.18e-05	6.52e-05	CcSEcCtD
Pramipexole—Nausea—Diazepam—epilepsy syndrome	1.17e-05	6.5e-05	CcSEcCtD
Pramipexole—Loss of consciousness—Gabapentin—epilepsy syndrome	1.17e-05	6.49e-05	CcSEcCtD
Pramipexole—Headache—Zonisamide—epilepsy syndrome	1.17e-05	6.49e-05	CcSEcCtD
Pramipexole—Dyspnoea—Valproic Acid—epilepsy syndrome	1.17e-05	6.48e-05	CcSEcCtD
Pramipexole—Diarrhoea—Carbamazepine—epilepsy syndrome	1.17e-05	6.48e-05	CcSEcCtD
Pramipexole—Angiopathy—Topiramate—epilepsy syndrome	1.17e-05	6.48e-05	CcSEcCtD
Pramipexole—Pruritus—Lamotrigine—epilepsy syndrome	1.17e-05	6.47e-05	CcSEcCtD
Pramipexole—Shock—Pregabalin—epilepsy syndrome	1.17e-05	6.47e-05	CcSEcCtD
Pramipexole—Somnolence—Valproic Acid—epilepsy syndrome	1.16e-05	6.46e-05	CcSEcCtD
Pramipexole—Immune system disorder—Topiramate—epilepsy syndrome	1.16e-05	6.45e-05	CcSEcCtD
Pramipexole—Nervous system disorder—Pregabalin—epilepsy syndrome	1.16e-05	6.45e-05	CcSEcCtD
Pramipexole—Cough—Gabapentin—epilepsy syndrome	1.16e-05	6.45e-05	CcSEcCtD
Pramipexole—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.16e-05	6.44e-05	CcSEcCtD
Pramipexole—Mediastinal disorder—Topiramate—epilepsy syndrome	1.16e-05	6.43e-05	CcSEcCtD
Pramipexole—Tachycardia—Pregabalin—epilepsy syndrome	1.16e-05	6.42e-05	CcSEcCtD
Pramipexole—Chills—Topiramate—epilepsy syndrome	1.15e-05	6.41e-05	CcSEcCtD
Pramipexole—Dyspepsia—Valproic Acid—epilepsy syndrome	1.15e-05	6.4e-05	CcSEcCtD
Pramipexole—Convulsion—Gabapentin—epilepsy syndrome	1.15e-05	6.4e-05	CcSEcCtD
Pramipexole—Skin disorder—Pregabalin—epilepsy syndrome	1.15e-05	6.39e-05	CcSEcCtD
Pramipexole—Hypertension—Gabapentin—epilepsy syndrome	1.15e-05	6.38e-05	CcSEcCtD
Pramipexole—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.15e-05	6.36e-05	CcSEcCtD
Pramipexole—Vomiting—Clonazepam—epilepsy syndrome	1.14e-05	6.35e-05	CcSEcCtD
Pramipexole—Decreased appetite—Valproic Acid—epilepsy syndrome	1.14e-05	6.32e-05	CcSEcCtD
Pramipexole—Alopecia—Topiramate—epilepsy syndrome	1.14e-05	6.31e-05	CcSEcCtD
Pramipexole—Vomiting—Phenytoin—epilepsy syndrome	1.14e-05	6.31e-05	CcSEcCtD
Pramipexole—Rash—Clonazepam—epilepsy syndrome	1.13e-05	6.3e-05	CcSEcCtD
Pramipexole—Dermatitis—Clonazepam—epilepsy syndrome	1.13e-05	6.29e-05	CcSEcCtD
Pramipexole—Myalgia—Gabapentin—epilepsy syndrome	1.13e-05	6.29e-05	CcSEcCtD
Pramipexole—Arthralgia—Gabapentin—epilepsy syndrome	1.13e-05	6.29e-05	CcSEcCtD
Pramipexole—Chest pain—Gabapentin—epilepsy syndrome	1.13e-05	6.29e-05	CcSEcCtD
Pramipexole—Nausea—Felbamate—epilepsy syndrome	1.13e-05	6.29e-05	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.13e-05	6.28e-05	CcSEcCtD
Pramipexole—Vomiting—Oxcarbazepine—epilepsy syndrome	1.13e-05	6.27e-05	CcSEcCtD
Pramipexole—Fatigue—Valproic Acid—epilepsy syndrome	1.13e-05	6.27e-05	CcSEcCtD
Pramipexole—Anxiety—Gabapentin—epilepsy syndrome	1.13e-05	6.27e-05	CcSEcCtD
Pramipexole—Anorexia—Pregabalin—epilepsy syndrome	1.13e-05	6.27e-05	CcSEcCtD
Pramipexole—Dizziness—Carbamazepine—epilepsy syndrome	1.13e-05	6.26e-05	CcSEcCtD
Pramipexole—Diarrhoea—Lamotrigine—epilepsy syndrome	1.13e-05	6.26e-05	CcSEcCtD
Pramipexole—Headache—Clonazepam—epilepsy syndrome	1.13e-05	6.26e-05	CcSEcCtD
Pramipexole—Rash—Phenytoin—epilepsy syndrome	1.13e-05	6.25e-05	CcSEcCtD
Pramipexole—Mental disorder—Topiramate—epilepsy syndrome	1.13e-05	6.25e-05	CcSEcCtD
Pramipexole—Dermatitis—Phenytoin—epilepsy syndrome	1.13e-05	6.25e-05	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.13e-05	6.25e-05	CcSEcCtD
Pramipexole—Rash—Oxcarbazepine—epilepsy syndrome	1.12e-05	6.22e-05	CcSEcCtD
Pramipexole—Pain—Valproic Acid—epilepsy syndrome	1.12e-05	6.22e-05	CcSEcCtD
Pramipexole—Constipation—Valproic Acid—epilepsy syndrome	1.12e-05	6.22e-05	CcSEcCtD
Pramipexole—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.12e-05	6.22e-05	CcSEcCtD
Pramipexole—Headache—Phenytoin—epilepsy syndrome	1.12e-05	6.21e-05	CcSEcCtD
Pramipexole—Malnutrition—Topiramate—epilepsy syndrome	1.12e-05	6.21e-05	CcSEcCtD
Pramipexole—Erythema—Topiramate—epilepsy syndrome	1.12e-05	6.21e-05	CcSEcCtD
Pramipexole—Discomfort—Gabapentin—epilepsy syndrome	1.12e-05	6.21e-05	CcSEcCtD
Pramipexole—Headache—Oxcarbazepine—epilepsy syndrome	1.11e-05	6.18e-05	CcSEcCtD
Pramipexole—Nausea—Zonisamide—epilepsy syndrome	1.11e-05	6.15e-05	CcSEcCtD
Pramipexole—Dry mouth—Gabapentin—epilepsy syndrome	1.11e-05	6.15e-05	CcSEcCtD
Pramipexole—Hypotension—Pregabalin—epilepsy syndrome	1.11e-05	6.14e-05	CcSEcCtD
Pramipexole—Flatulence—Topiramate—epilepsy syndrome	1.1e-05	6.12e-05	CcSEcCtD
Pramipexole—Tension—Topiramate—epilepsy syndrome	1.1e-05	6.1e-05	CcSEcCtD
Pramipexole—Dysgeusia—Topiramate—epilepsy syndrome	1.1e-05	6.09e-05	CcSEcCtD
Pramipexole—Confusional state—Gabapentin—epilepsy syndrome	1.1e-05	6.08e-05	CcSEcCtD
Pramipexole—Dizziness—Lamotrigine—epilepsy syndrome	1.09e-05	6.05e-05	CcSEcCtD
Pramipexole—Nervousness—Topiramate—epilepsy syndrome	1.09e-05	6.04e-05	CcSEcCtD
Pramipexole—Oedema—Gabapentin—epilepsy syndrome	1.09e-05	6.03e-05	CcSEcCtD
Pramipexole—Vomiting—Carbamazepine—epilepsy syndrome	1.08e-05	6.02e-05	CcSEcCtD
Pramipexole—Back pain—Topiramate—epilepsy syndrome	1.08e-05	6.01e-05	CcSEcCtD
Pramipexole—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.08e-05	5.99e-05	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.08e-05	5.99e-05	CcSEcCtD
Pramipexole—Infection—Gabapentin—epilepsy syndrome	1.08e-05	5.99e-05	CcSEcCtD
Pramipexole—Muscle spasms—Topiramate—epilepsy syndrome	1.08e-05	5.97e-05	CcSEcCtD
Pramipexole—Rash—Carbamazepine—epilepsy syndrome	1.08e-05	5.97e-05	CcSEcCtD
Pramipexole—Dermatitis—Carbamazepine—epilepsy syndrome	1.07e-05	5.96e-05	CcSEcCtD
Pramipexole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.07e-05	5.95e-05	CcSEcCtD
Pramipexole—Insomnia—Pregabalin—epilepsy syndrome	1.07e-05	5.95e-05	CcSEcCtD
Pramipexole—Nausea—Clonazepam—epilepsy syndrome	1.07e-05	5.93e-05	CcSEcCtD
Pramipexole—Headache—Carbamazepine—epilepsy syndrome	1.07e-05	5.93e-05	CcSEcCtD
Pramipexole—Shock—Gabapentin—epilepsy syndrome	1.07e-05	5.93e-05	CcSEcCtD
Pramipexole—Nervous system disorder—Gabapentin—epilepsy syndrome	1.07e-05	5.91e-05	CcSEcCtD
Pramipexole—Paraesthesia—Pregabalin—epilepsy syndrome	1.06e-05	5.9e-05	CcSEcCtD
Pramipexole—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.06e-05	5.9e-05	CcSEcCtD
Pramipexole—Nausea—Phenytoin—epilepsy syndrome	1.06e-05	5.89e-05	CcSEcCtD
Pramipexole—Tachycardia—Gabapentin—epilepsy syndrome	1.06e-05	5.88e-05	CcSEcCtD
Pramipexole—Dyspnoea—Pregabalin—epilepsy syndrome	1.06e-05	5.86e-05	CcSEcCtD
Pramipexole—Nausea—Oxcarbazepine—epilepsy syndrome	1.06e-05	5.86e-05	CcSEcCtD
Pramipexole—Vision blurred—Topiramate—epilepsy syndrome	1.06e-05	5.86e-05	CcSEcCtD
Pramipexole—Skin disorder—Gabapentin—epilepsy syndrome	1.05e-05	5.86e-05	CcSEcCtD
Pramipexole—Somnolence—Pregabalin—epilepsy syndrome	1.05e-05	5.84e-05	CcSEcCtD
Pramipexole—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.05e-05	5.83e-05	CcSEcCtD
Pramipexole—Tremor—Topiramate—epilepsy syndrome	1.05e-05	5.82e-05	CcSEcCtD
Pramipexole—Vomiting—Lamotrigine—epilepsy syndrome	1.05e-05	5.82e-05	CcSEcCtD
Pramipexole—Urticaria—Valproic Acid—epilepsy syndrome	1.04e-05	5.78e-05	CcSEcCtD
Pramipexole—Rash—Lamotrigine—epilepsy syndrome	1.04e-05	5.77e-05	CcSEcCtD
Pramipexole—Ill-defined disorder—Topiramate—epilepsy syndrome	1.04e-05	5.77e-05	CcSEcCtD
Pramipexole—Dermatitis—Lamotrigine—epilepsy syndrome	1.04e-05	5.76e-05	CcSEcCtD
Pramipexole—Abdominal pain—Valproic Acid—epilepsy syndrome	1.04e-05	5.75e-05	CcSEcCtD
Pramipexole—Body temperature increased—Valproic Acid—epilepsy syndrome	1.04e-05	5.75e-05	CcSEcCtD
Pramipexole—Anorexia—Gabapentin—epilepsy syndrome	1.04e-05	5.75e-05	CcSEcCtD
Pramipexole—Anaemia—Topiramate—epilepsy syndrome	1.03e-05	5.74e-05	CcSEcCtD
Pramipexole—Headache—Lamotrigine—epilepsy syndrome	1.03e-05	5.73e-05	CcSEcCtD
Pramipexole—Decreased appetite—Pregabalin—epilepsy syndrome	1.03e-05	5.71e-05	CcSEcCtD
Pramipexole—Agitation—Topiramate—epilepsy syndrome	1.03e-05	5.71e-05	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.02e-05	5.68e-05	CcSEcCtD
Pramipexole—Fatigue—Pregabalin—epilepsy syndrome	1.02e-05	5.67e-05	CcSEcCtD
Pramipexole—Hypotension—Gabapentin—epilepsy syndrome	1.01e-05	5.63e-05	CcSEcCtD
Pramipexole—Nausea—Carbamazepine—epilepsy syndrome	1.01e-05	5.62e-05	CcSEcCtD
Pramipexole—Constipation—Pregabalin—epilepsy syndrome	1.01e-05	5.62e-05	CcSEcCtD
Pramipexole—Pain—Pregabalin—epilepsy syndrome	1.01e-05	5.62e-05	CcSEcCtD
Pramipexole—Malaise—Topiramate—epilepsy syndrome	1.01e-05	5.6e-05	CcSEcCtD
Pramipexole—Vertigo—Topiramate—epilepsy syndrome	1.01e-05	5.58e-05	CcSEcCtD
Pramipexole—Syncope—Topiramate—epilepsy syndrome	1e-05	5.57e-05	CcSEcCtD
Pramipexole—Leukopenia—Topiramate—epilepsy syndrome	1e-05	5.56e-05	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	9.9e-06	5.49e-05	CcSEcCtD
Pramipexole—Palpitations—Topiramate—epilepsy syndrome	9.89e-06	5.49e-05	CcSEcCtD
Pramipexole—Loss of consciousness—Topiramate—epilepsy syndrome	9.84e-06	5.46e-05	CcSEcCtD
Pramipexole—Insomnia—Gabapentin—epilepsy syndrome	9.82e-06	5.45e-05	CcSEcCtD
Pramipexole—Nausea—Lamotrigine—epilepsy syndrome	9.79e-06	5.44e-05	CcSEcCtD
Pramipexole—Cough—Topiramate—epilepsy syndrome	9.77e-06	5.42e-05	CcSEcCtD
Pramipexole—Feeling abnormal—Pregabalin—epilepsy syndrome	9.76e-06	5.42e-05	CcSEcCtD
Pramipexole—Paraesthesia—Gabapentin—epilepsy syndrome	9.75e-06	5.41e-05	CcSEcCtD
Pramipexole—Convulsion—Topiramate—epilepsy syndrome	9.7e-06	5.38e-05	CcSEcCtD
Pramipexole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	9.69e-06	5.38e-05	CcSEcCtD
Pramipexole—Dyspnoea—Gabapentin—epilepsy syndrome	9.68e-06	5.37e-05	CcSEcCtD
Pramipexole—Hypertension—Topiramate—epilepsy syndrome	9.67e-06	5.37e-05	CcSEcCtD
Pramipexole—Somnolence—Gabapentin—epilepsy syndrome	9.66e-06	5.36e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Valproic Acid—epilepsy syndrome	9.65e-06	5.36e-05	CcSEcCtD
Pramipexole—Dyspepsia—Gabapentin—epilepsy syndrome	9.56e-06	5.31e-05	CcSEcCtD
Pramipexole—Chest pain—Topiramate—epilepsy syndrome	9.53e-06	5.29e-05	CcSEcCtD
Pramipexole—Arthralgia—Topiramate—epilepsy syndrome	9.53e-06	5.29e-05	CcSEcCtD
Pramipexole—Myalgia—Topiramate—epilepsy syndrome	9.53e-06	5.29e-05	CcSEcCtD
Pramipexole—Anxiety—Topiramate—epilepsy syndrome	9.5e-06	5.27e-05	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	9.47e-06	5.25e-05	CcSEcCtD
Pramipexole—Decreased appetite—Gabapentin—epilepsy syndrome	9.44e-06	5.24e-05	CcSEcCtD
Pramipexole—Discomfort—Topiramate—epilepsy syndrome	9.42e-06	5.23e-05	CcSEcCtD
Pramipexole—Urticaria—Pregabalin—epilepsy syndrome	9.41e-06	5.22e-05	CcSEcCtD
Pramipexole—Asthenia—Valproic Acid—epilepsy syndrome	9.4e-06	5.22e-05	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	9.38e-06	5.2e-05	CcSEcCtD
Pramipexole—Fatigue—Gabapentin—epilepsy syndrome	9.36e-06	5.2e-05	CcSEcCtD
Pramipexole—Body temperature increased—Pregabalin—epilepsy syndrome	9.36e-06	5.2e-05	CcSEcCtD
Pramipexole—Abdominal pain—Pregabalin—epilepsy syndrome	9.36e-06	5.2e-05	CcSEcCtD
Pramipexole—Dry mouth—Topiramate—epilepsy syndrome	9.32e-06	5.17e-05	CcSEcCtD
Pramipexole—Pain—Gabapentin—epilepsy syndrome	9.29e-06	5.15e-05	CcSEcCtD
Pramipexole—Constipation—Gabapentin—epilepsy syndrome	9.29e-06	5.15e-05	CcSEcCtD
Pramipexole—Pruritus—Valproic Acid—epilepsy syndrome	9.27e-06	5.14e-05	CcSEcCtD
Pramipexole—Confusional state—Topiramate—epilepsy syndrome	9.21e-06	5.11e-05	CcSEcCtD
Pramipexole—Oedema—Topiramate—epilepsy syndrome	9.14e-06	5.07e-05	CcSEcCtD
Pramipexole—Infection—Topiramate—epilepsy syndrome	9.08e-06	5.04e-05	CcSEcCtD
Pramipexole—Shock—Topiramate—epilepsy syndrome	8.99e-06	4.99e-05	CcSEcCtD
Pramipexole—Diarrhoea—Valproic Acid—epilepsy syndrome	8.96e-06	4.98e-05	CcSEcCtD
Pramipexole—Nervous system disorder—Topiramate—epilepsy syndrome	8.96e-06	4.97e-05	CcSEcCtD
Pramipexole—Feeling abnormal—Gabapentin—epilepsy syndrome	8.95e-06	4.97e-05	CcSEcCtD
Pramipexole—Thrombocytopenia—Topiramate—epilepsy syndrome	8.95e-06	4.97e-05	CcSEcCtD
Pramipexole—Tachycardia—Topiramate—epilepsy syndrome	8.92e-06	4.95e-05	CcSEcCtD
Pramipexole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	8.88e-06	4.93e-05	CcSEcCtD
Pramipexole—Skin disorder—Topiramate—epilepsy syndrome	8.88e-06	4.93e-05	CcSEcCtD
Pramipexole—Hyperhidrosis—Topiramate—epilepsy syndrome	8.83e-06	4.9e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Pregabalin—epilepsy syndrome	8.73e-06	4.84e-05	CcSEcCtD
Pramipexole—Anorexia—Topiramate—epilepsy syndrome	8.71e-06	4.83e-05	CcSEcCtD
Pramipexole—Dizziness—Valproic Acid—epilepsy syndrome	8.66e-06	4.81e-05	CcSEcCtD
Pramipexole—Urticaria—Gabapentin—epilepsy syndrome	8.63e-06	4.79e-05	CcSEcCtD
Pramipexole—Abdominal pain—Gabapentin—epilepsy syndrome	8.59e-06	4.77e-05	CcSEcCtD
Pramipexole—Body temperature increased—Gabapentin—epilepsy syndrome	8.59e-06	4.77e-05	CcSEcCtD
Pramipexole—Hypotension—Topiramate—epilepsy syndrome	8.54e-06	4.74e-05	CcSEcCtD
Pramipexole—Asthenia—Pregabalin—epilepsy syndrome	8.5e-06	4.72e-05	CcSEcCtD
Pramipexole—Pruritus—Pregabalin—epilepsy syndrome	8.38e-06	4.65e-05	CcSEcCtD
Pramipexole—Vomiting—Valproic Acid—epilepsy syndrome	8.33e-06	4.62e-05	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	8.33e-06	4.62e-05	CcSEcCtD
Pramipexole—Insomnia—Topiramate—epilepsy syndrome	8.26e-06	4.59e-05	CcSEcCtD
Pramipexole—Rash—Valproic Acid—epilepsy syndrome	8.26e-06	4.58e-05	CcSEcCtD
Pramipexole—Dermatitis—Valproic Acid—epilepsy syndrome	8.25e-06	4.58e-05	CcSEcCtD
Pramipexole—Headache—Valproic Acid—epilepsy syndrome	8.21e-06	4.56e-05	CcSEcCtD
Pramipexole—Paraesthesia—Topiramate—epilepsy syndrome	8.21e-06	4.55e-05	CcSEcCtD
Pramipexole—Dyspnoea—Topiramate—epilepsy syndrome	8.15e-06	4.52e-05	CcSEcCtD
Pramipexole—Somnolence—Topiramate—epilepsy syndrome	8.12e-06	4.51e-05	CcSEcCtD
Pramipexole—Diarrhoea—Pregabalin—epilepsy syndrome	8.1e-06	4.5e-05	CcSEcCtD
Pramipexole—Dyspepsia—Topiramate—epilepsy syndrome	8.04e-06	4.46e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Gabapentin—epilepsy syndrome	8e-06	4.44e-05	CcSEcCtD
Pramipexole—Decreased appetite—Topiramate—epilepsy syndrome	7.94e-06	4.41e-05	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Topiramate—epilepsy syndrome	7.89e-06	4.38e-05	CcSEcCtD
Pramipexole—Fatigue—Topiramate—epilepsy syndrome	7.88e-06	4.37e-05	CcSEcCtD
Pramipexole—Dizziness—Pregabalin—epilepsy syndrome	7.83e-06	4.35e-05	CcSEcCtD
Pramipexole—Pain—Topiramate—epilepsy syndrome	7.81e-06	4.34e-05	CcSEcCtD
Pramipexole—Constipation—Topiramate—epilepsy syndrome	7.81e-06	4.34e-05	CcSEcCtD
Pramipexole—Asthenia—Gabapentin—epilepsy syndrome	7.79e-06	4.33e-05	CcSEcCtD
Pramipexole—Nausea—Valproic Acid—epilepsy syndrome	7.78e-06	4.32e-05	CcSEcCtD
Pramipexole—Pruritus—Gabapentin—epilepsy syndrome	7.68e-06	4.26e-05	CcSEcCtD
Pramipexole—Vomiting—Pregabalin—epilepsy syndrome	7.53e-06	4.18e-05	CcSEcCtD
Pramipexole—Feeling abnormal—Topiramate—epilepsy syndrome	7.53e-06	4.18e-05	CcSEcCtD
Pramipexole—Gastrointestinal pain—Topiramate—epilepsy syndrome	7.47e-06	4.15e-05	CcSEcCtD
Pramipexole—Rash—Pregabalin—epilepsy syndrome	7.47e-06	4.14e-05	CcSEcCtD
Pramipexole—Dermatitis—Pregabalin—epilepsy syndrome	7.46e-06	4.14e-05	CcSEcCtD
Pramipexole—Diarrhoea—Gabapentin—epilepsy syndrome	7.43e-06	4.12e-05	CcSEcCtD
Pramipexole—Headache—Pregabalin—epilepsy syndrome	7.42e-06	4.12e-05	CcSEcCtD
Pramipexole—Urticaria—Topiramate—epilepsy syndrome	7.26e-06	4.03e-05	CcSEcCtD
Pramipexole—Abdominal pain—Topiramate—epilepsy syndrome	7.22e-06	4.01e-05	CcSEcCtD
Pramipexole—Body temperature increased—Topiramate—epilepsy syndrome	7.22e-06	4.01e-05	CcSEcCtD
Pramipexole—Dizziness—Gabapentin—epilepsy syndrome	7.18e-06	3.99e-05	CcSEcCtD
Pramipexole—Nausea—Pregabalin—epilepsy syndrome	7.04e-06	3.9e-05	CcSEcCtD
Pramipexole—Vomiting—Gabapentin—epilepsy syndrome	6.91e-06	3.83e-05	CcSEcCtD
Pramipexole—Rash—Gabapentin—epilepsy syndrome	6.85e-06	3.8e-05	CcSEcCtD
Pramipexole—Dermatitis—Gabapentin—epilepsy syndrome	6.84e-06	3.8e-05	CcSEcCtD
Pramipexole—Headache—Gabapentin—epilepsy syndrome	6.8e-06	3.78e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Topiramate—epilepsy syndrome	6.73e-06	3.74e-05	CcSEcCtD
Pramipexole—Asthenia—Topiramate—epilepsy syndrome	6.56e-06	3.64e-05	CcSEcCtD
Pramipexole—Pruritus—Topiramate—epilepsy syndrome	6.46e-06	3.59e-05	CcSEcCtD
Pramipexole—Nausea—Gabapentin—epilepsy syndrome	6.45e-06	3.58e-05	CcSEcCtD
Pramipexole—Diarrhoea—Topiramate—epilepsy syndrome	6.25e-06	3.47e-05	CcSEcCtD
Pramipexole—Dizziness—Topiramate—epilepsy syndrome	6.04e-06	3.35e-05	CcSEcCtD
Pramipexole—Vomiting—Topiramate—epilepsy syndrome	5.81e-06	3.22e-05	CcSEcCtD
Pramipexole—Rash—Topiramate—epilepsy syndrome	5.76e-06	3.2e-05	CcSEcCtD
Pramipexole—Dermatitis—Topiramate—epilepsy syndrome	5.76e-06	3.19e-05	CcSEcCtD
Pramipexole—Headache—Topiramate—epilepsy syndrome	5.72e-06	3.18e-05	CcSEcCtD
Pramipexole—Nausea—Topiramate—epilepsy syndrome	5.43e-06	3.01e-05	CcSEcCtD
Pramipexole—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	1.54e-06	1.69e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—FYN—epilepsy syndrome	1.53e-06	1.68e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	1.53e-06	1.68e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	1.53e-06	1.67e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	1.52e-06	1.67e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	1.52e-06	1.67e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	1.52e-06	1.67e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	1.51e-06	1.65e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.5e-06	1.65e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—POMC—epilepsy syndrome	1.5e-06	1.65e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	1.5e-06	1.65e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.5e-06	1.64e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	1.5e-06	1.64e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—AKT1—epilepsy syndrome	1.5e-06	1.64e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	1.5e-06	1.64e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	1.49e-06	1.64e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	1.49e-06	1.64e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	1.49e-06	1.63e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	1.49e-06	1.63e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.47e-06	1.62e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	1.47e-06	1.61e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—POMC—epilepsy syndrome	1.47e-06	1.61e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	1.46e-06	1.61e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	1.46e-06	1.6e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—POMC—epilepsy syndrome	1.46e-06	1.6e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NGF—epilepsy syndrome	1.46e-06	1.6e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	1.45e-06	1.59e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	1.45e-06	1.59e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.45e-06	1.59e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—POMC—epilepsy syndrome	1.45e-06	1.59e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	1.44e-06	1.58e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—FGF2—epilepsy syndrome	1.44e-06	1.58e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	1.44e-06	1.58e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CCL2—epilepsy syndrome	1.43e-06	1.57e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	1.43e-06	1.57e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	1.43e-06	1.57e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	1.43e-06	1.57e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	1.43e-06	1.57e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—SRC—epilepsy syndrome	1.42e-06	1.56e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	1.42e-06	1.56e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	1.42e-06	1.55e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCL2—epilepsy syndrome	1.42e-06	1.55e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	1.41e-06	1.55e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AGT—epilepsy syndrome	1.41e-06	1.54e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—POMC—epilepsy syndrome	1.4e-06	1.53e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	1.39e-06	1.53e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	1.39e-06	1.53e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	1.39e-06	1.52e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—VEGFA—epilepsy syndrome	1.39e-06	1.52e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	1.39e-06	1.52e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.38e-06	1.52e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—APOE—epilepsy syndrome	1.38e-06	1.51e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.38e-06	1.51e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.38e-06	1.51e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	1.38e-06	1.51e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.37e-06	1.5e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	1.37e-06	1.5e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ALB—epilepsy syndrome	1.37e-06	1.5e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.37e-06	1.5e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.36e-06	1.5e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	1.36e-06	1.49e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	1.36e-06	1.49e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.34e-06	1.47e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—RELA—epilepsy syndrome	1.34e-06	1.47e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.33e-06	1.46e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	1.33e-06	1.46e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ALB—epilepsy syndrome	1.33e-06	1.46e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.32e-06	1.45e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	1.32e-06	1.44e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AGT—epilepsy syndrome	1.32e-06	1.44e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MTOR—epilepsy syndrome	1.31e-06	1.44e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	1.31e-06	1.43e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	1.3e-06	1.43e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	1.3e-06	1.42e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	1.3e-06	1.42e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	1.29e-06	1.42e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—APOE—epilepsy syndrome	1.29e-06	1.41e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	1.28e-06	1.4e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	1.28e-06	1.4e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	1.28e-06	1.4e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ALB—epilepsy syndrome	1.27e-06	1.4e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	1.27e-06	1.39e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.27e-06	1.39e-05	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.26e-06	1.39e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—KDR—epilepsy syndrome	1.26e-06	1.38e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.26e-06	1.38e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.25e-06	1.38e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	1.25e-06	1.37e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	1.25e-06	1.37e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	1.24e-06	1.36e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.24e-06	1.36e-05	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.24e-06	1.36e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.23e-06	1.35e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.23e-06	1.35e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	1.23e-06	1.34e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	1.22e-06	1.34e-05	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—AKT1—epilepsy syndrome	1.22e-06	1.34e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	1.22e-06	1.33e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	1.22e-06	1.33e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	1.21e-06	1.33e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CASP3—epilepsy syndrome	1.21e-06	1.32e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—RELA—epilepsy syndrome	1.2e-06	1.32e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	1.2e-06	1.31e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.2e-06	1.31e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	1.19e-06	1.31e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.19e-06	1.31e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	1.19e-06	1.31e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—RELA—epilepsy syndrome	1.19e-06	1.3e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.19e-06	1.3e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	1.18e-06	1.3e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	1.18e-06	1.29e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.18e-06	1.29e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.18e-06	1.29e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.17e-06	1.29e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—JUN—epilepsy syndrome	1.17e-06	1.28e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	1.16e-06	1.28e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	1.16e-06	1.28e-05	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.16e-06	1.27e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	1.16e-06	1.27e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	1.16e-06	1.27e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.15e-06	1.27e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	1.15e-06	1.26e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.15e-06	1.26e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	1.14e-06	1.25e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.13e-06	1.24e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.12e-06	1.23e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	1.12e-06	1.23e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.12e-06	1.22e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.12e-06	1.22e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	1.11e-06	1.22e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—POMC—epilepsy syndrome	1.11e-06	1.21e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	1.11e-06	1.21e-05	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.1e-06	1.2e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	1.09e-06	1.2e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	1.09e-06	1.19e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	1.09e-06	1.19e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.09e-06	1.19e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	1.09e-06	1.19e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.08e-06	1.19e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	1.08e-06	1.19e-05	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.08e-06	1.19e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.08e-06	1.19e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	1.08e-06	1.18e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	1.07e-06	1.18e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	1.07e-06	1.18e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	1.07e-06	1.17e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	1.07e-06	1.17e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.06e-06	1.17e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.06e-06	1.16e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—JUN—epilepsy syndrome	1.05e-06	1.16e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	1.05e-06	1.15e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SRC—epilepsy syndrome	1.05e-06	1.15e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—JUN—epilepsy syndrome	1.04e-06	1.14e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.04e-06	1.14e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.04e-06	1.14e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	1.03e-06	1.13e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	1.03e-06	1.13e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	1.02e-06	1.12e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.02e-06	1.11e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	1.01e-06	1.11e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	1.01e-06	1.11e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	1e-06	1.1e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	1e-06	1.1e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	9.95e-07	1.09e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	9.91e-07	1.09e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	9.82e-07	1.08e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	9.82e-07	1.08e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	9.79e-07	1.07e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	9.77e-07	1.07e-05	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	9.76e-07	1.07e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	9.7e-07	1.06e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	9.67e-07	1.06e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	9.63e-07	1.06e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SRC—epilepsy syndrome	9.46e-07	1.04e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	9.45e-07	1.04e-05	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	9.42e-07	1.03e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	9.39e-07	1.03e-05	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	9.38e-07	1.03e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	9.34e-07	1.02e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SRC—epilepsy syndrome	9.33e-07	1.02e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	9.29e-07	1.02e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	9.21e-07	1.01e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	9.14e-07	1e-05	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	9.12e-07	1e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	9.09e-07	9.97e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RELA—epilepsy syndrome	9.09e-07	9.97e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	9.07e-07	9.95e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	9.03e-07	9.91e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	9.02e-07	9.9e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	8.94e-07	9.81e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	8.91e-07	9.78e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	8.87e-07	9.72e-06	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	8.85e-07	9.7e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	8.82e-07	9.68e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	8.78e-07	9.63e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	8.78e-07	9.63e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	8.77e-07	9.62e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	8.76e-07	9.61e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	8.56e-07	9.39e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	8.54e-07	9.36e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	8.51e-07	9.34e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	8.43e-07	9.24e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	8.28e-07	9.08e-06	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	8.27e-07	9.07e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	8.21e-07	9e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	8.2e-07	8.99e-06	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.14e-07	8.93e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	8.14e-07	8.92e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	8.14e-07	8.92e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	8.09e-07	8.88e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	8.07e-07	8.85e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	7.98e-07	8.75e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—JUN—epilepsy syndrome	7.96e-07	8.73e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	7.92e-07	8.69e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	7.88e-07	8.65e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	7.87e-07	8.63e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	7.83e-07	8.59e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	7.75e-07	8.5e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	7.67e-07	8.41e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	7.62e-07	8.36e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	7.51e-07	8.24e-06	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.41e-07	8.12e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	7.39e-07	8.11e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	7.34e-07	8.05e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SRC—epilepsy syndrome	7.14e-07	7.83e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	7.13e-07	7.82e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	7.03e-07	7.71e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	6.96e-07	7.63e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	6.94e-07	7.61e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	6.84e-07	7.51e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	6.78e-07	7.43e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	6.73e-07	7.38e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	6.64e-07	7.28e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	6.53e-07	7.16e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	6.39e-07	7.01e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	6.23e-07	6.84e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	6.23e-07	6.83e-06	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AKT1—epilepsy syndrome	6.01e-07	6.6e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	5.88e-07	6.45e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AKT1—epilepsy syndrome	5.85e-07	6.42e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	5.8e-07	6.36e-06	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AKT1—epilepsy syndrome	5.61e-07	6.15e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	5.24e-07	5.74e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	5.06e-07	5.54e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	5.03e-07	5.52e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	4.89e-07	5.37e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AKT1—epilepsy syndrome	4.75e-07	5.21e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	4.44e-07	4.87e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	4.37e-07	4.79e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	3.97e-07	4.36e-06	CbGpPWpGaD
